617 studies found for:    "ulcerative colitis"
Show Display Options
RSS Create an RSS feed from your search for:
"ulcerative colitis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Conditions: Ulcerative Colitis;   Left-sided Ulcerative Colitis;   Distal Ulcerative Colitis
Interventions: Drug: Zoenasa-1:4;   Drug: Mesalamine Enema
2 Recruiting TD-1473 for Active Ulcerative Colitis (UC)
Conditions: Ulcerative Colitis, Active Moderate;   Ulcerative Colitis, Active Severe
Interventions: Drug: TD-1473;   Drug: Placebo
3 Recruiting Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative Colitis
Conditions: Ulcerative Colitis, Active Moderate;   Ulcerative Colitis, Active Severe
Interventions: Biological: Bertilimumab;   Biological: Placebo
4 Unknown  Melatonin & Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Dietary Supplement: Melatonin;   Other: Placebo
5 Not yet recruiting Ulcerative Colitis Relapse Prevention by Prebiotics
Condition: Ulcerative Colitis
Interventions: Dietary Supplement: Synergy-1;   Dietary Supplement: Maltodextrin
6 Completed Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Asacol (mesalamine)
7 Recruiting Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention:
8 Withdrawn Vitamin D Treatment in Ulcerative Colitis
Conditions: Ulcerative Colitis;   Inflammatory Bowel Disease
Interventions: Drug: Vitamin D3;   Other: Placebo
9 Completed Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Mesalamin
10 Recruiting Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Infliximab
11 Completed Ulcerative Colitis Relapse Prevention Trial, Hypnosis
Conditions: Ulcerative Colitis;   Inflammatory Bowel Disease
Interventions: Behavioral: Hypnotherapy;   Behavioral: Standard care;   Behavioral: Mind Body Therapy
12 Completed Chromoendoscopy for Ulcerative Colitis Surveillance
Conditions: Ulcerative Colitis;   Crohn's Disease
Intervention: Procedure: Chromoendoscopy with magnification
13 Unknown  Epidemiology of Ulcerative Colitis and Crohn's Disease in Non Jewish Israel Population
Conditions: Ulcerative Colitis;   Crohn's Disease
Intervention:
14 Terminated An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Visilizumab (Nuvion®; HuM291)
15 Terminated Basiliximab Maintenance in Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Basiliximab
16 Recruiting Special Investigation in Patients With Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention:
17 Terminated Endomicroscopy in Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Device: PENTAX EC-3870CIFK / EC-3870CILK confocal colonoscopes
18 Recruiting Low Dose IL-2 for Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Interleukin-2 (aldesleukin).
19 Terminated Effects of Probiotics in Patients With Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Dietary Supplement: Kyo-Dophilus;   Dietary Supplement: placebo
20 Unknown  Oral OKT3 for the Treatment of Active Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Oral OKT3

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years